Medtronic plc [MDT] Is Currently 0.44 below its 200 Period Moving Avg: What Does This Mean?

Related

Medtronic plc [NYSE: MDT] closed the trading session at $105.62. The company report on January 10, 2022 that Medtronic announces regulatory approval and launch in Japan of Micra AV Transcatheter Pacing System.

World’s smallest pacemaker can now treat patients with AV block, bringing miniaturized, leadless pacing to more patients.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has received approval from Japan’s Ministry of Health, Labor and Welfare for the sale and reimbursement of the Micra™ AV Transcatheter Pacing System (TPS), and the company will launch the product this month.

The stocks have a year to date performance of 2.10 percent and weekly performance of -0.45 percent. The stock has been moved at -17.10 percent over the last six months. The stock has performed -6.37 percent around the most recent 30 days and changed -14.51 percent over the most recent 3-months.

If compared to the average trading volume of 6.68M shares, MDT reached to a volume of 6451547 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Medtronic plc [MDT]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MDT shares is $130.24 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MDT stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

BTIG Research have made an estimate for Medtronic plc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on January 10, 2022. While these analysts kept the previous recommendation, Morgan Stanley dropped their target price from $145 to $120. The new note on the price target was released on January 07, 2022, representing the official price target for Medtronic plc stock. Previously, the target price had yet another drop from $152 to $110, while Piper Sandler kept a Neutral rating on MDT stock. On December 17, 2021, analysts decreased their price target for MDT shares from 130 to 105.

The Average True Range (ATR) for Medtronic plc is set at 2.47, with the Price to Sales ratio for MDT stock in the period of the last 12 months amounting to 4.46. The Price to Book ratio for the last quarter was 2.73, with the Price to Cash per share for the same quarter was set at 7.95. Price to Free Cash Flow for MDT in the course of the last twelve months was 56.31 with Quick ratio for the last quarter at 2.40.

MDT stock trade performance evaluation

Medtronic plc [MDT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.45. With this latest performance, MDT shares dropped by -6.37% in over the last four-week period, additionally sinking by -17.10% over the last 6 months – not to mention a drop of -10.87% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MDT stock in for the last two-week period is set at 45.55, with the RSI for the last a single of trading hit 50.49, and the three-weeks RSI is set at 42.78 for Medtronic plc [MDT]. The present Moving Average for the last 50 days of trading for this stock 111.33, while it was recorded at 105.63 for the last single week of trading, and 122.98 for the last 200 days.

Medtronic plc [MDT]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Medtronic plc [MDT] shares currently have an operating margin of +18.38 and a Gross Margin at +59.70. Medtronic plc’s Net Margin is presently recorded at +11.97.

Return on Total Capital for MDT is now 7.11, given the latest momentum, and Return on Invested Capital for the company is 4.74. Return on Equity for this stock inclined to 7.06, with Return on Assets sitting at 3.92. When it comes to the capital structure of this company, Medtronic plc [MDT] has a Total Debt to Total Equity ratio set at 53.29. Additionally, MDT Total Debt to Total Capital is recorded at 34.76, with Total Debt to Total Assets ending up at 29.44. Long-Term Debt to Equity for the company is recorded at 52.90, with the Long-Term Debt to Total Capital now at 34.51.

Reflecting on the efficiency of the workforce at the company, Medtronic plc [MDT] managed to generate an average of $40,067 per employee. Receivables Turnover for the company is 5.96 with a Total Asset Turnover recorded at a value of 0.33.Medtronic plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.40 and a Current Ratio set at 2.90.

Earnings per share (EPS) analysis for Medtronic plc [MDT] stock

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MDT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Medtronic plc go to 11.46%.

>> 7 Top Picks for the Post-Pandemic Economy <<

Medtronic plc [MDT]: Insider Ownership positions

There are presently around $113,274 million, or 83.10% of MDT stock, in the hands of institutional investors. The top three institutional holders of MDT stocks are: VANGUARD GROUP INC with ownership of 112,499,622, which is approximately 0.644% of the company’s market cap and around 0.23% of the total institutional ownership; BLACKROCK INC., holding 103,020,182 shares of the stock with an approximate value of $10.88 billion in MDT stocks shares; and STATE STREET CORP, currently with $5.96 billion in MDT stock with ownership of nearly 0.958% of the company’s market capitalization.

1,041 institutional holders increased their position in Medtronic plc [NYSE:MDT] by around 29,185,944 shares. Additionally, 770 investors decreased positions by around 36,272,892 shares, while 283 investors held positions by with 1,007,008,256 shares. The mentioned changes placed institutional holdings at 1,072,467,092 shares, according to the latest SEC report filing. MDT stock had 113 new institutional investments in for a total of 3,814,359 shares, while 81 institutional investors sold positions of 3,508,634 shares during the same period.